Azelastine (Astepro) Nasal Spray for Allergic Rhinitis
A new formulation of the H1-antihistamine azelastine hydrochloride 0.1% nasal spray (Astepro - Meda) has been approved by the FDA for treatment of seasonal allergic rhinitis (SAR) in patients ≥12 years old and is being heavily advertised to the public on radio, television and the Internet. All azelastine products require a prescription....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Azelastine (Astepro) Nasal Spray for Allergic Rhinitis
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1310
Article Code: 1310a
Date: April 20, 2009
Volume: 51
Pages: 29-30
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1310
Article Code: 1310a
Date: April 20, 2009
Volume: 51
Pages: 29-30
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)